Clinical and Experimental Pharmacology and Physiology Issues Research Articles in March 2022 Edition
March 09, 2022
March 09, 2022
TUGGERAH, Australia, March 9 -- Clinical and Experimental Pharmacology and Physiology, a peer-reviewed journal from the High Blood Pressure Research Council of Australia, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and Australian Physiological Society, published research articles on the following topics in its March 2022 edition:
ORIGINAL ARTICLES:
* 2E-Decene-4,6-diyn-1-ol-acetate inhibits osteoclastogenesis through mitogen-acti . . .
ORIGINAL ARTICLES:
* 2E-Decene-4,6-diyn-1-ol-acetate inhibits osteoclastogenesis through mitogen-acti . . .